Back to Search
NELSON WATTS, M.D.
M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1740238229IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
35-079959(OH)
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
35-079959(OH)
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 1969
Research & Publications (20)
Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment.
PMID 19113918·J Bone Miner Res·2009
2-rct
Fracture risk remains reduced one year after discontinuation of risedronate.
PMID 17938986·Osteoporos Int·2008
2-rct
Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
PMID 16294263·J Bone Miner Res·2005
1-meta
The American College of Endocrinology and Endocrine University.
PMID 17060978·Trans Am Clin Climatol Assoc·2004
8-other
Is it ethical to use placebos in osteoporosis clinical trials?
PMID 14713406·Curr Rheumatol Rep·2004
6-review
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
PMID 15319494·J Clin Densitom·2004
3-trial
Is it ethical to use placebos in osteoporosis clinical trials?
PMID 16036080·Curr Osteoporos Rep·2004
4-observational
Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA).
PMID 15322740·Osteoporos Int·2004
5-case
Risedronate prevents new vertebral fractures in postmenopausal women at high risk.
PMID 12574177·J Clin Endocrinol Metab·2003
3-trial
Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate.
PMID 12730756·Osteoporos Int·2003
3-trial
Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
PMID 11829081·J Reprod Med·2002
6-review
The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK.
PMID 19547906·Osteoporos Int·2010
8-other
Risk factors for the development of osteoporosis and osteoporotic fractures among older men.
PMID 19605671·J Rheumatol·2009
8-other
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.
PMID 19468663·Osteoporos Int·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4760 E GALBRAITH RD, STE 208
CINCINNATI, OH 45236 - Phone
- (513) 686-2663
Quick Facts
- NPI
- 1740238229
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 57
- Publications
- 20
Are you this provider?
Claim Your Profile